应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
TELO Telomir Pharmaceuticals
交易中 01-06 12:01:14 EST
4.40
-0.12
-2.65%
最高
4.62
最低
4.24
成交量
5.44万
今开
4.47
昨收
4.52
日振幅
8.41%
总市值
1.30亿
流通市值
7,685万
总股本
2,961万
成交额
24.28万
换手率
0.31%
流通股本
1,746万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Telomir Pharmaceuticals, Inc.盘中异动 快速拉升6.63%报4.34美元
市场透视 · 01-04
Telomir Pharmaceuticals, Inc.盘中异动 快速拉升6.63%报4.34美元
Telomir Pharmaceuticals, Inc.盘中异动 急速上涨5.10%
市场透视 · 01-02
Telomir Pharmaceuticals, Inc.盘中异动 急速上涨5.10%
Telomir Pharmaceuticals, Inc.盘中异动 早盘快速下跌5.17%报4.40美元
市场透视 · 2024-12-31
Telomir Pharmaceuticals, Inc.盘中异动 早盘快速下跌5.17%报4.40美元
Telomir Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.54%
市场透视 · 2024-12-30
Telomir Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.54%
Telomir Pharmaceuticals, Inc.盘中异动 早盘急速拉升5.20%
市场透视 · 2024-12-27
Telomir Pharmaceuticals, Inc.盘中异动 早盘急速拉升5.20%
Telomir Pharmaceuticals, Inc.盘中异动 股价大跌5.23%
市场透视 · 2024-12-27
Telomir Pharmaceuticals, Inc.盘中异动 股价大跌5.23%
Telomir Pharmaceuticals, Inc.盘中异动 大幅拉升6.87%报4.98美元
市场透视 · 2024-12-24
Telomir Pharmaceuticals, Inc.盘中异动 大幅拉升6.87%报4.98美元
Telomir Pharmaceuticals, Inc.盘中异动 股价大跌7.92%
市场透视 · 2024-12-23
Telomir Pharmaceuticals, Inc.盘中异动 股价大跌7.92%
Telomir Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.07%报4.77美元
市场透视 · 2024-12-21
Telomir Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.07%报4.77美元
Telomir Pharmaceuticals, Inc.盘中异动 临近收盘大幅下跌5.70%
市场透视 · 2024-12-19
Telomir Pharmaceuticals, Inc.盘中异动 临近收盘大幅下跌5.70%
Telomir Pharmaceuticals, Inc.盘中异动 股价大跌5.00%
市场透视 · 2024-12-16
Telomir Pharmaceuticals, Inc.盘中异动 股价大跌5.00%
Telomir Pharmaceuticals, Inc.盘中异动 早盘股价大跌11.39%
市场透视 · 2024-12-13
Telomir Pharmaceuticals, Inc.盘中异动 早盘股价大跌11.39%
Telomir Pharmaceuticals, Inc.盘中异动 快速跳水5.20%
市场透视 · 2024-12-11
Telomir Pharmaceuticals, Inc.盘中异动 快速跳水5.20%
Telomir Pharmaceuticals, Inc.盘中异动 急速跳水5.10%报5.50美元
市场透视 · 2024-12-10
Telomir Pharmaceuticals, Inc.盘中异动 急速跳水5.10%报5.50美元
Telomir Pharmaceuticals, Inc.盘中异动 急速下挫5.83%报6.14美元
市场透视 · 2024-12-09
Telomir Pharmaceuticals, Inc.盘中异动 急速下挫5.83%报6.14美元
Telomir Pharmaceuticals, Inc.盘中异动 早盘急速上涨5.57%报5.88美元
市场透视 · 2024-12-06
Telomir Pharmaceuticals, Inc.盘中异动 早盘急速上涨5.57%报5.88美元
Telomir Pharmaceuticals, Inc.盘中异动 急速拉升5.12%
市场透视 · 2024-12-05
Telomir Pharmaceuticals, Inc.盘中异动 急速拉升5.12%
Telomir Pharmaceuticals, Inc.盘中异动 股价大涨5.65%报4.49美元
市场透视 · 2024-12-03
Telomir Pharmaceuticals, Inc.盘中异动 股价大涨5.65%报4.49美元
Telomir Pharmaceuticals, Inc.盘中异动 早盘股价大涨7.04%
市场透视 · 2024-12-02
Telomir Pharmaceuticals, Inc.盘中异动 早盘股价大涨7.04%
Telomir Pharmaceuticals, Inc.盘中异动 急速跳水5.84%
市场透视 · 2024-11-29
Telomir Pharmaceuticals, Inc.盘中异动 急速跳水5.84%
加载更多
公司概况
公司名称:
Telomir Pharmaceuticals
所属市场:
NASDAQ
上市日期:
--
主营业务:
Telomir Pharmaceuticals, Inc.于2021年8月成立为佛罗里达州的一家公司。该公司是一家临床前阶段制药公司,专注于TELOMIR-1的开发和商业化,TELOMIR-1是一种正在开发的新型小分子,可作为人类干细胞的口服原位治疗性治疗。原位干细胞疗法利用人体的自然资源来再生受损组织,并用新的功能性细胞取代细胞。
发行价格:
--
{"stockData":{"symbol":"TELO","market":"US","secType":"STK","nameCN":"Telomir Pharmaceuticals","latestPrice":4.4,"timestamp":1736182809647,"preClose":4.52,"halted":0,"volume":54359,"delay":0,"floatShares":17464990,"shares":29609814,"eps":-0.794562,"marketStatus":"交易中","change":-0.12,"latestTime":"01-06 12:01:14 EST","open":4.47,"high":4.62,"low":4.24,"amount":242801.92068300003,"amplitude":0.084071,"askPrice":4.46,"askSize":410,"bidPrice":4.4,"bidSize":205,"shortable":3,"etf":0,"ttmEps":-0.794562,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1736197200000},"marketStatusCode":2,"adr":0,"listingDate":1707454800000,"exchange":"NASDAQ","adjPreClose":4.52,"preHourTrading":{"tag":"盘前","latestPrice":4.48,"preClose":4.52,"latestTime":"08:57 EST","volume":7,"amount":31.360000000000003,"timestamp":1736171833232},"postHourTrading":{"tag":"盘后","latestPrice":4.44,"preClose":4.52,"latestTime":"18:40 EST","volume":2748,"amount":12400.96,"timestamp":1735947643866},"volumeRatio":0.841516},"requestUrl":"/m/hq/s/TELO","defaultTab":"news","newsList":[{"id":"2500145856","title":"Telomir Pharmaceuticals, Inc.盘中异动 快速拉升6.63%报4.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500145856","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500145856?lang=zh_cn&edition=full","pubTime":"2025-01-04 00:07","pubTimestamp":1735920436,"startTime":"0","endTime":"0","summary":"北京时间2025年01月04日00时07分,Telomir Pharmaceuticals, Inc.股票出现波动,股价大幅拉升6.63%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.50%。Telomir Pharmaceuticals, Inc.公司简介:Telomir Pharmaceuticals Inc是一家处于临床前阶段的先锋制药公司,引领抗衰老科学的发展。Telomir正在对早衰症、糖尿病、癌症、阿尔茨海默病、骨关节炎等进行持续的临床前研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250104000716985a4dd1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250104000716985a4dd1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TELO"],"gpt_icon":0},{"id":"2500975944","title":"Telomir Pharmaceuticals, Inc.盘中异动 急速上涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500975944","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500975944?lang=zh_cn&edition=full","pubTime":"2025-01-02 22:34","pubTimestamp":1735828494,"startTime":"0","endTime":"0","summary":"北京时间2025年01月02日22时34分,Telomir Pharmaceuticals, Inc.股票出现异动,股价快速上涨5.10%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.79%。Telomir Pharmaceuticals, Inc.公司简介:Telomir Pharmaceuticals Inc是一家处于临床前阶段的先锋制药公司,引领抗衰老科学的发展。通过在细胞层面解决衰老的根本原因,Telomir旨在解决这些疾病的根源,而不仅仅是治疗症状。Telomir正在对早衰症、糖尿病、癌症、阿尔茨海默病、骨关节炎等进行持续的临床前研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501022234549858fc3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501022234549858fc3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"2495614308","title":"Telomir Pharmaceuticals, Inc.盘中异动 早盘快速下跌5.17%报4.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2495614308","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495614308?lang=zh_cn&edition=full","pubTime":"2024-12-31 23:03","pubTimestamp":1735657432,"startTime":"0","endTime":"0","summary":"北京时间2024年12月31日23时03分,Telomir Pharmaceuticals, Inc.股票出现波动,股价急速下挫5.17%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.44%。Telomir Pharmaceuticals, Inc.公司简介:Telomir Pharmaceuticals Inc是一家处于临床前阶段的先锋制药公司,引领抗衰老科学的发展。通过在细胞层面解决衰老的根本原因,Telomir旨在解决这些疾病的根源,而不仅仅是治疗症状。Telomir正在对早衰症、糖尿病、癌症、阿尔茨海默病、骨关节炎等进行持续的临床前研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123123035295f43426&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123123035295f43426&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TELO"],"gpt_icon":0},{"id":"2495934521","title":"Telomir Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2495934521","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495934521?lang=zh_cn&edition=full","pubTime":"2024-12-30 23:20","pubTimestamp":1735572050,"startTime":"0","endTime":"0","summary":"北京时间2024年12月30日23时20分,Telomir Pharmaceuticals, Inc.股票出现异动,股价大幅跳水5.54%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为1.19%。Telomir Pharmaceuticals, Inc.公司简介:Telomir Pharmaceuticals Inc是一家处于临床前阶段的先锋制药公司,引领抗衰老科学的发展。通过在细胞层面解决衰老的根本原因,Telomir旨在解决这些疾病的根源,而不仅仅是治疗症状。Telomir正在对早衰症、糖尿病、癌症、阿尔茨海默病、骨关节炎等进行持续的临床前研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123023205095f2cef6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123023205095f2cef6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TELO"],"gpt_icon":0},{"id":"2494386040","title":"Telomir Pharmaceuticals, Inc.盘中异动 早盘急速拉升5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2494386040","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494386040?lang=zh_cn&edition=full","pubTime":"2024-12-27 22:38","pubTimestamp":1735310294,"startTime":"0","endTime":"0","summary":"北京时间2024年12月27日22时38分,Telomir Pharmaceuticals, Inc.股票出现波动,股价急速上涨5.20%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.12%。Telomir Pharmaceuticals, Inc.公司简介:Telomir Pharmaceuticals Inc是一家处于临床前阶段的先锋制药公司,引领抗衰老科学的发展。通过在细胞层面解决衰老的根本原因,Telomir旨在解决这些疾病的根源,而不仅仅是治疗症状。Telomir正在对早衰症、糖尿病、癌症、阿尔茨海默病、骨关节炎等进行持续的临床前研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202412272238159851d4b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202412272238159851d4b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TELO"],"gpt_icon":0},{"id":"2494789342","title":"Telomir Pharmaceuticals, Inc.盘中异动 股价大跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2494789342","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494789342?lang=zh_cn&edition=full","pubTime":"2024-12-27 01:49","pubTimestamp":1735235348,"startTime":"0","endTime":"0","summary":"北京时间2024年12月27日01时49分,Telomir Pharmaceuticals, Inc.股票出现波动,股价急速下跌5.23%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.23%。Telomir Pharmaceuticals, Inc.公司简介:Telomir Pharmaceuticals Inc是一家处于临床前阶段的先锋制药公司,引领抗衰老科学的发展。通过在细胞层面解决衰老的根本原因,Telomir旨在解决这些疾病的根源,而不仅仅是治疗症状。Telomir正在对早衰症、糖尿病、癌症、阿尔茨海默病、骨关节炎等进行持续的临床前研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122701490898506c7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122701490898506c7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TELO"],"gpt_icon":0},{"id":"2493082713","title":"Telomir Pharmaceuticals, Inc.盘中异动 大幅拉升6.87%报4.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493082713","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493082713?lang=zh_cn&edition=full","pubTime":"2024-12-24 22:32","pubTimestamp":1735050759,"startTime":"0","endTime":"0","summary":"北京时间2024年12月24日22时32分,Telomir Pharmaceuticals, Inc.股票出现波动,股价急速拉升6.87%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.13%。Telomir Pharmaceuticals, Inc.公司简介:Telomir Pharmaceuticals Inc是一家处于临床前阶段的先锋制药公司,引领抗衰老科学的发展。通过在细胞层面解决衰老的根本原因,Telomir旨在解决这些疾病的根源,而不仅仅是治疗症状。Telomir正在对早衰症、糖尿病、癌症、阿尔茨海默病、骨关节炎等进行持续的临床前研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122422323995eb24bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122422323995eb24bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TELO"],"gpt_icon":0},{"id":"2493764184","title":"Telomir Pharmaceuticals, Inc.盘中异动 股价大跌7.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493764184","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493764184?lang=zh_cn&edition=full","pubTime":"2024-12-23 22:31","pubTimestamp":1734964291,"startTime":"0","endTime":"0","summary":"北京时间2024年12月23日22时31分,Telomir Pharmaceuticals, Inc.股票出现波动,股价急速下跌7.92%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.02%。其相关个股中,Traws Pharma, Inc.、Gt Biopharma, Inc.、Rapt Therapeutics, Inc.涨幅较大,Phio Pharmaceuticals Corp.、Gt Biopharma, Inc.、Traws Pharma, Inc.较为活跃,换手率分别为652.28%、433.60%、256.35%,振幅较大的相关个股有Traws Pharma, Inc.、Gt Biopharma, Inc.、Tenaya Therapeutics, Inc.,振幅分别为23.50%、12.03%、10.78%。Telomir Pharmaceuticals, Inc.公司简介:Telomir Pharmaceuticals Inc是一家处于临床前阶段的先锋制药公司,引领抗衰老科学的发展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223223131a2050a8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223223131a2050a8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TELO"],"gpt_icon":0},{"id":"2493442570","title":"Telomir Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.07%报4.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493442570","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493442570?lang=zh_cn&edition=full","pubTime":"2024-12-21 00:23","pubTimestamp":1734711818,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日00时23分,Telomir Pharmaceuticals, Inc.股票出现波动,股价快速拉升5.07%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.14%。Telomir Pharmaceuticals, Inc.公司简介:Telomir Pharmaceuticals Inc是一家处于临床前阶段的先锋制药公司,引领抗衰老科学的发展。通过在细胞层面解决衰老的根本原因,Telomir旨在解决这些疾病的根源,而不仅仅是治疗症状。Telomir正在对早衰症、糖尿病、癌症、阿尔茨海默病、骨关节炎等进行持续的临床前研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221002338984cfe4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221002338984cfe4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TELO"],"gpt_icon":0},{"id":"2492151501","title":"Telomir Pharmaceuticals, Inc.盘中异动 临近收盘大幅下跌5.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492151501","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492151501?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:42","pubTimestamp":1734554521,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时42分,Telomir Pharmaceuticals, Inc.股票出现异动,股价大幅跳水5.70%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为2.94%。Telomir Pharmaceuticals, Inc.公司简介:Telomir Pharmaceuticals Inc是一家处于临床前阶段的先锋制药公司,引领抗衰老科学的发展。通过在细胞层面解决衰老的根本原因,Telomir旨在解决这些疾病的根源,而不仅仅是治疗症状。Telomir正在对早衰症、糖尿病、癌症、阿尔茨海默病、骨关节炎等进行持续的临床前研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121904420295ea5b1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121904420295ea5b1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TELO"],"gpt_icon":0},{"id":"2491724690","title":"Telomir Pharmaceuticals, Inc.盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491724690","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491724690?lang=zh_cn&edition=full","pubTime":"2024-12-16 23:07","pubTimestamp":1734361670,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日23时07分,Telomir Pharmaceuticals, Inc.股票出现异动,股价急速跳水5.00%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.50%。其相关个股中,Tonix Pharmaceuticals Holding Corp.、Cardio Diagnostics Holdings Inc C/Wts To Pur Com、Viridian Therapeutics, Inc.涨幅较大,Tonix Pharmaceuticals Holding Corp.、Dermata Therapeutics, Inc.、Genprex, Inc.较为活跃,换手率分别为67.28%、33.45%、33.37%,振幅较大的相关个股有Cardio Diagnostics Holdings Inc C/Wts To Pur Com、Larimar Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.,振幅分别为46.95%、35.01%、27.03%。Telomir Pharmaceuticals, Inc.公司简介:Telomir Pharmaceuticals Inc是一家处于临床前阶段的先锋制药公司,引领抗衰老科学的发展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216230750984c725d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216230750984c725d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"2491756863","title":"Telomir Pharmaceuticals, Inc.盘中异动 早盘股价大跌11.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491756863","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491756863?lang=zh_cn&edition=full","pubTime":"2024-12-13 22:31","pubTimestamp":1734100292,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日22时31分,Telomir Pharmaceuticals, Inc.股票出现异动,股价快速跳水11.39%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.16%。Telomir Pharmaceuticals, Inc.公司简介:Telomir Pharmaceuticals Inc是一家处于临床前阶段的先锋制药公司,引领抗衰老科学的发展。通过在细胞层面解决衰老的根本原因,Telomir旨在解决这些疾病的根源,而不仅仅是治疗症状。Telomir正在对早衰症、糖尿病、癌症、阿尔茨海默病、骨关节炎等进行持续的临床前研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213223133a1ec328d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213223133a1ec328d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TELO"],"gpt_icon":0},{"id":"2490986689","title":"Telomir Pharmaceuticals, Inc.盘中异动 快速跳水5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490986689","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490986689?lang=zh_cn&edition=full","pubTime":"2024-12-11 23:07","pubTimestamp":1733929655,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日23时07分,Telomir Pharmaceuticals, Inc.股票出现异动,股价快速下挫5.20%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.39%。Telomir Pharmaceuticals, Inc.公司简介:Telomir Pharmaceuticals Inc是一家处于临床前阶段的先锋制药公司,引领抗衰老科学的发展。通过在细胞层面解决衰老的根本原因,Telomir旨在解决这些疾病的根源,而不仅仅是治疗症状。Telomir正在对早衰症、糖尿病、癌症、阿尔茨海默病、骨关节炎等进行持续的临床前研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211230735ab6fdd4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211230735ab6fdd4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TELO"],"gpt_icon":0},{"id":"2490846043","title":"Telomir Pharmaceuticals, Inc.盘中异动 急速跳水5.10%报5.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490846043","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490846043?lang=zh_cn&edition=full","pubTime":"2024-12-10 22:36","pubTimestamp":1733841400,"startTime":"0","endTime":"0","summary":"北京时间2024年12月10日22时36分,Telomir Pharmaceuticals, Inc.股票出现异动,股价快速跳水5.10%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.32%。Telomir Pharmaceuticals, Inc.公司简介:Telomir Pharmaceuticals Inc是一家处于临床前阶段的先锋制药公司,引领抗衰老科学的发展。通过在细胞层面解决衰老的根本原因,Telomir旨在解决这些疾病的根源,而不仅仅是治疗症状。Telomir正在对早衰症、糖尿病、癌症、阿尔茨海默病、骨关节炎等进行持续的临床前研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210223640ab6cf83e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210223640ab6cf83e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"2490776065","title":"Telomir Pharmaceuticals, Inc.盘中异动 急速下挫5.83%报6.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490776065","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490776065?lang=zh_cn&edition=full","pubTime":"2024-12-09 22:35","pubTimestamp":1733754920,"startTime":"0","endTime":"0","summary":"北京时间2024年12月09日22时35分,Telomir Pharmaceuticals, Inc.股票出现异动,股价快速跳水5.83%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.41%。Telomir Pharmaceuticals, Inc.公司简介:Telomir Pharmaceuticals Inc是一家处于临床前阶段的先锋制药公司,引领抗衰老科学的发展。通过在细胞层面解决衰老的根本原因,Telomir旨在解决这些疾病的根源,而不仅仅是治疗症状。Telomir正在对早衰症、糖尿病、癌症、阿尔茨海默病、骨关节炎等进行持续的临床前研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209223520ab6a0bc6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209223520ab6a0bc6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"2489236908","title":"Telomir Pharmaceuticals, Inc.盘中异动 早盘急速上涨5.57%报5.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489236908","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489236908?lang=zh_cn&edition=full","pubTime":"2024-12-06 22:34","pubTimestamp":1733495663,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日22时34分,Telomir Pharmaceuticals, Inc.股票出现异动,股价急速拉升5.57%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.04%。Telomir Pharmaceuticals, Inc.公司简介:Telomir Pharmaceuticals Inc是一家处于临床前阶段的先锋制药公司,引领抗衰老科学的发展。通过在细胞层面解决衰老的根本原因,Telomir旨在解决这些疾病的根源,而不仅仅是治疗症状。Telomir正在对早衰症、糖尿病、癌症、阿尔茨海默病、骨关节炎等进行持续的临床前研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120622342398e5e1a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120622342398e5e1a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TELO"],"gpt_icon":0},{"id":"2489714793","title":"Telomir Pharmaceuticals, Inc.盘中异动 急速拉升5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489714793","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489714793?lang=zh_cn&edition=full","pubTime":"2024-12-05 05:00","pubTimestamp":1733346016,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日05时00分,Telomir Pharmaceuticals, Inc.股票出现波动,股价急速上涨5.12%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.80%。Telomir Pharmaceuticals, Inc.公司简介:Telomir Pharmaceuticals Inc 是一家临床前阶段的制药公司,专注于Telomir -1的开发和商业化,Telomir -1是一种新型小分子,正在开发用于人类干细胞的口服原位治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205050017a1d471d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205050017a1d471d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"2488594614","title":"Telomir Pharmaceuticals, Inc.盘中异动 股价大涨5.65%报4.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488594614","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488594614?lang=zh_cn&edition=full","pubTime":"2024-12-03 22:33","pubTimestamp":1733236394,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日22时33分,Telomir Pharmaceuticals, Inc.股票出现异动,股价快速拉升5.65%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.07%。Telomir Pharmaceuticals, Inc.公司简介:Telomir Pharmaceuticals Inc 是一家临床前阶段的制药公司,专注于Telomir -1的开发和商业化,Telomir -1是一种新型小分子,正在开发用于人类干细胞的口服原位治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203223314abf2f96c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203223314abf2f96c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TELO"],"gpt_icon":0},{"id":"2488677374","title":"Telomir Pharmaceuticals, Inc.盘中异动 早盘股价大涨7.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488677374","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488677374?lang=zh_cn&edition=full","pubTime":"2024-12-02 22:52","pubTimestamp":1733151155,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日22时52分,Telomir Pharmaceuticals, Inc.股票出现异动,股价快速上涨7.04%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.06%。Telomir Pharmaceuticals, Inc.公司简介:Telomir Pharmaceuticals Inc 是一家临床前阶段的制药公司,专注于Telomir -1的开发和商业化,Telomir -1是一种新型小分子,正在开发用于人类干细胞的口服原位治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202225235abf00c3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202225235abf00c3b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TELO","BK4007"],"gpt_icon":0},{"id":"2487181569","title":"Telomir Pharmaceuticals, Inc.盘中异动 急速跳水5.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2487181569","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487181569?lang=zh_cn&edition=full","pubTime":"2024-11-29 23:46","pubTimestamp":1732895165,"startTime":"0","endTime":"0","summary":"北京时间2024年11月29日23时46分,Telomir Pharmaceuticals, Inc.股票出现异动,股价快速下挫5.84%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.13%。Telomir Pharmaceuticals, Inc.公司简介:Telomir Pharmaceuticals Inc 是一家临床前阶段的制药公司,专注于Telomir -1的开发和商业化,Telomir -1是一种新型小分子,正在开发用于人类干细胞的口服原位治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129234605a25f9aed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129234605a25f9aed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TELO","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.telomirpharma.com","stockEarnings":[{"period":"1week","weight":-0.0719},{"period":"1month","weight":-0.124},{"period":"3month","weight":-0.1676},{"period":"6month","weight":0.0439},{"period":"1year","weight":-0.3543},{"period":"ytd","weight":0.0971}],"compareEarnings":[{"period":"1week","weight":-0.0051},{"period":"1month","weight":-0.0259},{"period":"3month","weight":0.0331},{"period":"6month","weight":0.0673},{"period":"1year","weight":0.2668},{"period":"ytd","weight":0.01}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Telomir Pharmaceuticals, Inc.于2021年8月成立为佛罗里达州的一家公司。该公司是一家临床前阶段制药公司,专注于TELOMIR-1的开发和商业化,TELOMIR-1是一种正在开发的新型小分子,可作为人类干细胞的口服原位治疗性治疗。原位干细胞疗法利用人体的自然资源来再生受损组织,并用新的功能性细胞取代细胞。","exchange":"NASDAQ","name":"Telomir Pharmaceuticals","nameEN":"Telomir Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Telomir Pharmaceuticals(TELO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Telomir Pharmaceuticals(TELO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Telomir Pharmaceuticals,TELO,Telomir Pharmaceuticals股票,Telomir Pharmaceuticals股票老虎,Telomir Pharmaceuticals股票老虎国际,Telomir Pharmaceuticals行情,Telomir Pharmaceuticals股票行情,Telomir Pharmaceuticals股价,Telomir Pharmaceuticals股市,Telomir Pharmaceuticals股票价格,Telomir Pharmaceuticals股票交易,Telomir Pharmaceuticals股票购买,Telomir Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Telomir Pharmaceuticals(TELO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Telomir Pharmaceuticals(TELO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}